Joseph Group Capital Management
Source: SEC Form 13F · as of Mar 2026Joseph Group Capital Management holds 24 biotech & pharma companies tracked by BioSniper, totaling $17.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$17.1M
| Company | Shares | Value |
|---|---|---|
| AMGNAMGEN INC | 13,392 | $4.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 10,514 | $4.7M |
| LLYELI LILLY & Co | 5,035 | $4.6M |
| MEDPMedpace Holdings Inc. | 4,420 | $2.1M |
| ABBVAbbVie Inc. | 1,188 | $258K |
| JNJJOHNSON & JOHNSON | 683 | $167K |
| ABTABBOTT LABORATORIES | 1,072 | $110K |
| MRKMerck & Co., Inc. | 466 | $56K |
| PMPhilip Morris International Inc | 276 | $46K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 139 | $38K |
| GILDGILEAD SCIENCES, INC. | 252 | $35K |
| PFEPFIZER INC | 973 | $27K |
| REGNREGENERON PHARMACEUTICALS, INC. | 31 | $24K |
| MCKMcKesson Corporation | 27 | $23K |
| BMYBRISTOL MYERS SQUIBB CO | 352 | $21K |
| GMOptec International, Inc. | 286 | $21K |
| CAHCardinal Health Inc. | 79 | $17K |
| ZTSZoetis Inc. | 91 | $11K |
| IDXXIDEXX LABORATORIES INC /DE | 18 | $10K |
| GEHCGE HealthCare Technologies Inc. | 104 | $7K |
| BIIBBIOGEN INC. | 36 | $7K |
| CORCencora Inc. | 21 | $7K |
| ELVElevance Health Inc. | 21 | $6K |
| IQVIQVIA Holdings Inc. | 32 | $5K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.